| Cas No.: | 1224846-01-8 |
| Chemical Name: | N-((5,6-dimethoxypyridin-2-yl)methyl)-5'-methyl-5-(thiazol-2-yl)-[2,3'-bipyridine]-4-carboxamide |
| Synonyms: | MK-3697; MK3697; MK 3697. |
| SMILES: | O=C(C1=CC(C2=CC(C)=CN=C2)=NC=C1C3=NC=CS3)NCC4=NC(OC)=C(OC)C=C4 |
| Formula: | C23H21N5O3S |
| M.Wt: | 447.51 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | MK-3697 is a third insomnia drug, currently being developed by Merck. MK-3697 is a potent and selective Orexin receptor antagonist with Ki = 0.95 nM. For the detailed information of MK3697, the solubility of MK3697 in water, the solubility of MK3697 in DMSO, the solubility of MK3697 in PBS buffer, the animal experiment (test) of MK3697, the cell expriment (test) of MK3697, the in vivo, in vitro and clinical trial test of MK3697, the EC50, IC50,and Affinity of MK3697, Please contact DC Chemicals. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|